Ignite Creation Date:
2024-05-06 @ 2:58 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02168634
Status:
UNKNOWN
Last Update Posted:
2015-10-09
First Post:
2014-03-11
Brief Title:
The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial
Sponsor:
Kaohsiung Veterans General Hospital
Organization:
Kaohsiung Veterans General Hospital
Study Overview
Official Title:
The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2015-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypertrophic scar a disfiguring tissue reaction to trauma occurred in around 20 of the population The patients with hypertrophic scar usually seek medical assistance not just for the annoying appearance but mostly due to the intractable itchiness There have been a variety of effective methods to alter the appearance of the scar However the treatments for itching from hypertrophic scar are scarce In 2009 PGazerani used Botox to treat histamine-induced itch with favorable results In the clinical setting however the efficacy of Botox to treat itch from hypertrophic scar was yet to be proven Therefore the goal of this study is to conduct a randomized controlled trials about using Botox to treat itch from hypertrophic scar
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None